Advertisement
Screener

IGNYTA, INC. Patents: Expired

IGNYTA, INC. Expired Patents

17 granted patents the USPTO lists as expired; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2019-05-31: Application 16466005; Invention METHODS FOR THE TREATMENT OF CANCER; Applicant IGNYTA, INC.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2018-06-15: Application 16063170; Invention COMBINATIONS FOR THE TREATMENT OF CANCER; Applicant IGNYTA, INC.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2017-07-13: Application 15649526; Invention URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS; Applicant IGNYTA, INC.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2017-06-23: Application 15632248; Invention SOLID STATE FORMS OF A QUINAZOLINE DERIVATIVE AND ITS USE AS A BRAF INHIBITOR; Applicant IGNYTA, INC.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2019-05-3116466005METHODS FOR THE TREATMENT OF CANCERIGNYTA, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622020-10-1310799503US20200069688A1
Jonathan Ee-Ren Lim
Pratik S. Multani
Richard Landin
Rupal A. Patel
Jennifer Wright Oliver
United States
United States
United States
United States
United States
WARD, PAUL V
2018-06-1516063170COMBINATIONS FOR THE TREATMENT OF CANCERIGNYTA, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622020-12-2210869864US20190000840A1
Gang LI
Ge WEI
Zachary D. HORNBY
Jonathan Ee-ren LIM
United States
United States
United States
United States
PIHONAK, SARAH
2017-07-1315649526URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORSIGNYTA, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622018-07-1010017496US20170320853A1
Reddeppa Reddy DANDU
Robert L. HUDKINS
Kurt A. JOSEF
Catherine P. PROUTY
Rabindranath TRIPATHY
United States
United States
United States
United States
United States
BALASUBRAMANIAN, VENKATARAMAN
2017-06-2315632248SOLID STATE FORMS OF A QUINAZOLINE DERIVATIVE AND ITS USE AS A BRAF INHIBITORIGNYTA, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622018-06-059987281US20170290833A1
Stephen J. BIERLMAIER
Ralph C. HALTIWANGER
Martin J. JACOBS
United States
United States
United States
RAO, DEEPAK R
2017-03-1015456439BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAMEIGNYTA, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622018-03-139913827US20170182008A1
Roger P. Bakale
Peter D. Brown
Jian Chen
Anthony S. Drager
Rachel Y. LaBell
Robert E. McKean
Piyush R. Patel
Renee C. Roemmele
United States
United States
United States
United States
United States
United States
United States
United States
STOCKTON, LAURA LYNNE
2016-11-0815346582URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORSIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622017-08-299745283US20170050949A1
Reddeppa Reddy Dandu
Robert L. Hudkins
Kurt A. Josef
Catherine P. Prouty
Rabindranath Tripathy
United States
United States
United States
United States
United States
BALASUBRAMANIAN, VENKATARAMAN
2016-06-2715108400PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USEIGNYTA, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622018-03-139914731US20160318929A1
Robert L Hudkins
Allison L. Zulli
United States
United States
CARTER, KENDRA D
2016-06-1615184968BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAMEIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622017-04-259630926US20160289198A1
Roger P. BAKALE
Peter D. BROWN
Jian CHEN
Anthony S. DRAGER
Rachel Y. LABELL
Robert E. MCKEAN
Piyush R. PATEL
Renee C. ROEMMELE
United States
United States
United States
United States
United States
United States
United States
United States
STOCKTON, LAURA LYNNE
2016-04-2515137922SOLID STATE FORMS OF A QUINAZOLINE DERIVATIVE AND ITS USE AS A BRAF INHIBITORIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622017-08-019718810US20160280698A1
Stephen J. Bierlmaier
Ralph C. Haltiwanger
Martin J. Jacobs
United States
United States
United States
RAO, DEEPAK R
2016-01-2514907514METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR IN COMBINATION WITH OTHER AGENTSIGNYTA, INC.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622018-07-2410028956US20160184309A1
Thelma S. Angeles
Mark A. Ator
Mangeng M. Cheng
Bruce Dorsey
Robert L. Hudkins
Bruce A. Ruggeri
United States
United States
United States
United States
United States
United States
WEDDINGTON, KEVIN E
2015-06-2214746666SOLID STATE FORMS OF A QUINAZOLINE DERIVATIVE AND ITS USE AS A BRAF INHIBITORIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622016-05-319353097US20150376171A1
Stephen J. Bierlmaier
Ralph C. Haltiwanger
Martin J. Jacobs
United States
United States
United States
RAO, DEEPAK R
2015-05-1314711747BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAMEIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-10-069149464US20150246023A1
Roger P. BAKALE
Peter D. BROWN
Jian CHEN
Anthony S. DRAGER
Rachel Y. LABELL
Robert E. MCKEAN
Piyush R. PATEL
Renee C. ROEMMELE
United States
United States
United States
United States
United States
United States
United States
United States
STOCKTON, LAURA LYNNE
2015-05-1114442088BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAMEIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622016-09-279452988US20150274675A1
Roger P. Bakale
Peter D. Brown
Jian Chen
Anthony S. Drager
Rachel Y. Labell
Robert E. McKean
Piyush R. Patel
Renee C. Roemmele
Bradley McIntyre
United States
United States
United States
United States
United States
United States
United States
United States
United States
STOCKTON, LAURA LYNNE
2015-04-2914699965BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAMEIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-10-069150517US20150232427A1
Roger P. BAKALE
Peter D. BROWN
Jian CHEN
Anthony S. DRAGER
Rachel Y. LABELL
Robert E. MCKEAN
Piyush R. PATEL
Renee C. ROEMMELE
United States
United States
United States
United States
United States
United States
United States
United States
STOCKTON, LAURA LYNNE
2015-04-0814681981URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORSIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-09-019120778US20150210670A1
Reddeppa Reddy Dandu
Robert L. Hudkins
Kurt A. Josef
Catherine P. Prouty
Rabindranath Tripathy
United States
United States
United States
United States
United States
BALASUBRAMANIAN, VENKATARAMAN
2015-04-0814681974URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORSIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622016-12-209522902US20150209358A1
Reddeppa Reddy Dandu
Robert L. Hudkins
Kurt A. Josef
Catherine P. Prouty
Rabindranath Tripathy
United States
United States
United States
United States
United States
BALASUBRAMANIAN, VENKATARAMAN
2014-05-1314276138URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORSIgnyta, Inc.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-05-129029538US20140275077A1
Reddeppa Reddy Dandu
Robert L. Hudkins
Kurt A. Josef
Catherine P. Prouty
Rabindranath Tripathy
United States
United States
United States
United States
United States
BALASUBRAMANIAN, VENKATARAMAN